# Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis

> **NCT00010439** · PHASE2 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 10 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Alendronate

## Key facts

- **NCT ID:** NCT00010439
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** 2003-10
- **Final completion:** 2008-11
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2010-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00010439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00010439, "Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00010439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*